BNTX
BioNTech SE · Healthcare · Biotechnology
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 760.71K | $74.78M | n/a | n/a |
| Q2 2026 | 94 | 0 | 32.40M | $3.02B | +8 | −8 |
| Q1 2026 | 95 | +4 | 29.16M | $2.59B | +13 | −9 |
| Q4 2025 | 91 | +4 | 29.39M | $2.80B | +4 | n/a |
| Q3 2025 | 13 | +1 | 23.37M | $2.30B | +1 | n/a |
| Q2 2025 | 9 | -3 | 22.65M | $2.41B | +1 | −4 |
| Q1 2025 | 10 | -2 | 14.39M | $1.31B | n/a | −2 |
| Q4 2024 | 12 | -1 | 14.53M | $1.66B | +1 | −2 |
| Q3 2024 | 12 | +1 | 13.93M | $1.65B | +3 | −2 |
| Q2 2024 | 11 | n/a | 15.47M | $1.24B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 8.28M | n/a | $665.08M | 0.5% | n/c | 1 | SEC ↗ ×4 |
| 2 | PRIMECAP Management ✦ | 4.79M | n/a | $384.89M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Capital World Investors ✦ | 955.98K | n/a | $76.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 654.12K | n/a | $52.56M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 461.71K | n/a | $37.10M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 101.50K | n/a | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 68.55K | n/a | $5.51M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 66.21K | n/a | $5.32M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 52.20K | n/a | $4.20M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 35.98K | n/a | $2.89M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 11.65K | n/a | $936,435 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 272 tenedores, 47.28M acciones, $3.59B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, 10% owner · 36.21K acc. · $3.45M
Officer, 10% owner · 27.00K acc. · $2.49M
Officer, 10% owner · 24.00K acc. · $2.30M
Officer, 10% owner · 21.00K acc. · $2.03M
Officer, 10% owner · 72.00K acc. · $7.00M
Officer, 10% owner · 17.00K acc. · $1.64M
Officer, 10% owner · 17.00K acc. · $1.66M
Officer, 10% owner · 32.00K acc. · $3.14M
Officer, 10% owner · 34.00K acc. · $3.34M
Officer, 10% owner · 34.00K acc. · $3.35M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología